TCF7L2 and exocrine pancreatic carcinoma: To identify TCF7L2 binding loci in a comprehensive manner, we performed ChIP-seq using an antibody to TCF7L2 and profiled six human cell types, including colorectal carcinoma cells (HCT116), hepatocellular carcinoma cells (HepG2), embryonic kidney cells (HEK293), mammary gland adenocarcinoma cells (MCF7), cervical carcinoma cells (HeLa), and pancreatic carcinoma cells (PANC1).